Skip to main content
Log in

The epidemiology of abnormal hemoglobins in Mediterranean high-level athletes

  • Original Article
  • Published:
European Journal of Applied Physiology Aims and scope Submit manuscript

Abstract

The aim of this study was to determine the prevalence and nature of hemoglobin (Hb) defects in a Mediterranean high-level (HL) athlete population. Five hundred and ninety-four HL male and female athletes were recruited during the annual follow-up of the members of Tunisian national teams. Hematological data, Hb electrophoresis, and DNA analysis were assessed using conventional techniques. Sporting discipline, type of sport, and performance levels were assessed using a questionnaire. The results showed that 32 HL athletes had abnormal Hb (5.4%): β-thalassemia (2.2%), α-thalassemia (0.5%), HbAS (1.5%), HbAC (0.5%), and rare Hb variants (0.7%). Of the 32 defect carriers, all but one (a α-thalassemia) were heterozygous. All the detected hemoglobinopathies but one (an Hb Hope) had already been reported in the country. The prevalence of Hb defect in the HL athletes was similar to that described in the general Tunisian population (P > 0.05). The percentage of Hb defect in the athletes was not dependent on gender, or performance level (P > 0.05). Within each type of sport the percentages of athletes with normal and abnormal Hb were similar (P > 0.05). The hematological data revealed the diversity of anemia, microcytosis, and hypochromia in thalassemic HL athletes. We concluded that HL athletes in Tunisia were a representative sample of the general Tunisian population regarding the prevalence and nature of benign abnormal Hb. The hematological data of the thalassemia carriers exhibited high variability and raised the question of genetic and sporting counseling, as well as biological follow-up for these carriers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Baysal E, Huisman TH (1994) Detection of common deletional alpha-thalassemia-2 determinants by PCR. Am J Hematol 46:208–213

    Article  CAS  PubMed  Google Scholar 

  • Bianco I, Cappabianca MP, Foglietta E, Lerone M, Deidda G, Morlupi L, Grisanti P, Ponzini D, Rinaldi S, Graziani B (1997) Silent thalassemias: genotypes and phenotypes. Haematologica 82:269–280

    CAS  PubMed  Google Scholar 

  • Bile A, Le Gallais D, Mercier J, Bogui P, Préfaut C (1998) Sickle cell trait in Ivory Coast athletic throw and jump champions, 1956–1995. Int J Sports Med 19:1–5

    Article  Google Scholar 

  • Bowden DK, Vickers MA, Higgs DR (1992) A PCR-based strategy to detect the common severe determinants of alpha-thalassaemia. Br J Haematol 81:104–108

    Article  CAS  PubMed  Google Scholar 

  • Chatard JC, Mujika I, Guy C, Lacour JR (1999) Anaemia and iron deficiency in athletes. Practical recommendations for treatment. Sports Med 27:229–240

    Article  CAS  PubMed  Google Scholar 

  • Chebil-Laradi S, Pousse H, Khelif A, Ghanem N, Martin J, Kortas M, Ennabli S, Mehdouani K, B’Chir N, Kharrat H (1994) Screening of hemoglobinopathies and molecular analysis of beta-thalassemia in Central Tunisia. Arch Pediatr 1:1100–1105

    CAS  PubMed  Google Scholar 

  • Chong SS, Boehm CD, Higgs DR (2000) Single-tube multiplex-PCR screen for common deletional of α-thalassemia. Blood 95:360–362

    CAS  PubMed  Google Scholar 

  • Connes P, Hue O, Tripette J, Hardy-Dessources MD (2008) Blood rheology abnormalities and vascular cell adhesion mechanisms in sickle cell trait carriers during exercise. Clin Hemorheol Microcirc 39:179–184

    PubMed  Google Scholar 

  • Fallon KE (2008) Screening for haematological and iron-related abnormalities in elite athletes-analysis of 576 cases. J Sci Med Sport 11:329–336

    Article  PubMed  Google Scholar 

  • Fattoum S (2006) Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data. Tunis Med 84:687–696

    PubMed  Google Scholar 

  • Fattoum S, Abbes S (1985) Some data on the epidemiology of hemoglobinopathies in Tunisia. Hemoglobin 9:423–429

    Article  CAS  PubMed  Google Scholar 

  • Fattoum S, Abbes S, Ben Abdeladhim A, Zayani H, Turky F, Guemira F, Sellami M, Ghanem A, Boussen M (1987) Detection of alpha-thalassemia in Tunisia (across 1500 cases). Tunis Med 65:763–766

    CAS  PubMed  Google Scholar 

  • Fattoum S, Massaoud T, Bibi A (2004) Molecular basis of β-thalassemia in the population of Tunisia. Hemoglobin 28:177–187

    Article  CAS  PubMed  Google Scholar 

  • Ghanem N, Girodon E, Vidaud M, Martin J, Fanen P, Plassa F, Goosens M (1992) A comprehensive scanning method for rapid detection of beta-globin gene mutations and polymorphisms. Hum Mutat 1:229–239

    Article  CAS  PubMed  Google Scholar 

  • Gonzalez-Redonto JM, Stoming TA, Kutlar A, Kutlar F, Lanclos KD, Howard EF, fei YJ, Aksoy M, Altay C, Gurgey A, Basak AN, Efremov GD, Petkov G, Huisman THJ (1989) AC → T substitution at nt–101 in a conserved DNA sequence of the promotor region of the β-globin gene is associated with “silent” β-thalassemia. Blood 73:1705–1711

    Google Scholar 

  • Haj Khelil A, Laradi S, Miled A, Omar Tadmouri G, Ben Chibani J, Perrin P (2004) Clinical and molecular aspects of haemoglobinopathies in Tunisia. Clin Chem Acta 340:127–137

    Article  CAS  Google Scholar 

  • Hickman M, Modell B, Grengross P, Chapman C, Layton M, Falconer S, Davies SC (1999) Mapping the prevalence of sickle cell and beta thalassaemia in England: estimating and validating ethnic-specific rates. Br J Haematol 104:860–867

    Article  CAS  PubMed  Google Scholar 

  • Ingle J, Adewoye A, Dewan R, Okoli M, Rollins L, Eung SH, Luo HY, Chui DH, Steinberg MH (2004) Hb Hope [beta136(H14)Gly– > Asp (GGT– > GAT)]: interactions with HbS [beta6(A3)Glu– > Val (GAG– > GTG)], others variant hemoglobins and thalassemia. Hemoglobin 28:277–285

    Article  CAS  PubMed  Google Scholar 

  • Joutovsky A, Nardi M (2004) Hemoglobin C and hemoglobin O-Arab variants can be diagnosed using the Bio-Rad Variant II high-performance liquid chromatography system without further confirmatory tests. Arch Pathol Lab Med 128:435–439

    CAS  PubMed  Google Scholar 

  • Le Gallais D, Préfaut C, Dulat C, Macabies J, Lonsdorfer J (1991) Sickle cell trait in Ivory Coast Athletic champions. Int J Sports Med 12:509–510

    Article  CAS  PubMed  Google Scholar 

  • Le Gallais D, Préfaut C, Mercier J, Bilé A, Bogui P, Lonsdorfer J (1994) Sickle cell trait as a limiting factor for high-level performance in a semi-marathon. Int J Sports Med 15:399–402

    Article  CAS  PubMed  Google Scholar 

  • Maggio A, Giambona A, Cai SP, Wall J, Kan YW, Chehab FF (1993) Rapid and simultaneous typing of hemoglobin S, hemoglobin C, and seven Mediterranean β-thalassemia mutations by covalent reverse dot-blot analysis: application diagnosis in Sicily. Blood 81:239–242

    CAS  PubMed  Google Scholar 

  • Marlin L, Etienne-Julan M, Le Gallais D, Hue O (2005) Sickle cell trait in French West Indian elite sprint athletes. Int J Sports Med 26:622–625

    Article  CAS  PubMed  Google Scholar 

  • Michlitsch J, Azimi M, Hoppe C, Walters MC, Lubin B, Lorey F, Vichinsky E (2009) Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer 52:486–490

    Article  PubMed  Google Scholar 

  • Monchanin G, Connes P, Wouassi D, Francina A, Djoda B, Banga PE, Owona FX, Thiriet P, Massarelli R, Martin C (2005) Hemorheology, Sickle Cell Trait, and alpha-thalassemia in athletes: effects of exercise. Med Sci Sports Exerc 37:1086–1092

    Article  CAS  PubMed  Google Scholar 

  • Mseddi S, Gargouri J, Labiadh Z, Kassis M, Elloumi M, Ghali L, Dammak J, Harrabi M, Souissi T, Frikha M (1999) Prevalence of haemoglobin abnormalities in Kebili (Tunisian south). Rev Epidemiol Santé Publique 47:29–36

    CAS  PubMed  Google Scholar 

  • Panigrahi I, Ahmed Rafeeq PH, Choudhry VP, Saxena R (2004) High frequency of deletional α-thalassemia in β-thalassemia trait: implications for genetic counselling. Am J Hematol 76:297–299

    Article  CAS  PubMed  Google Scholar 

  • Ristaldi MS, Murru S, Loudianos G, Casula L, Porcu S, Pigheddu D, Fanni B, Sciarratta GV, Agosti S, Parodi MI, Leone D, Camaschella C, Serra A, Pirastu M, Cao A (1990) The C–T substitution in the distal CACCC box of the β-globin gene promoter is a common cause of silent β thalassaemia in the Italian population. Br J Haematol 74:480–486

    Article  CAS  PubMed  Google Scholar 

  • Sambrook J, Maniatis T, Fritsch EF (1989) Molecular cloning. A laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Woodbury

    Google Scholar 

  • Shaskey DJ, Green GA (2000) Sports haematology. Sports Med 29:27–38

    Article  CAS  PubMed  Google Scholar 

  • Siala H, Ouali F, Massaoud T et al (2008) Alpha-thalassaemia in Tunisia: some epidemiological and molecular data. J Genet 87:229–234

    Article  CAS  PubMed  Google Scholar 

  • Thein SL (2005) Genetic modifiers of β-thalassemia. Haematologica 90:460–649

    Google Scholar 

  • Thiriet P, Lobe MM, Gweha I, Gozal D (1991) Prevalence of the sickle cell trait in athletic West African population. Med Sci Sports Exerc 23:389–390

    CAS  PubMed  Google Scholar 

  • Thiriet P, Hesran JY, Wouassi D, Bitanga E, Gozal D, Louis FJ (1994) Sickle cell trait performance in a prolonged race at high altitude. Med Sci Sport Exerc 26:914–918

    CAS  Google Scholar 

  • Tripette J, Hardy-dessources MD, Sara F et al (2007) Does repeated and heavy exercise impair blood rheology in carriers of sickle cell trait? Clin J Sport Med 17:465–470

    Article  PubMed  Google Scholar 

  • Van Kirk R, Sandhaus LM, Hoyer JD (2005) The detection and diagnosis of hemoglobin A2’ by high-performance liquid chromatography. Am J Clin Pathol 123:657–661

    Article  PubMed  Google Scholar 

  • Weight LM, Klein M, Noakes TD, Jacobs P (1992) “Sports anemia” a real or apparent phenomenon in endurance-trained athletes? Int J Sports Med 13:344–347

    Article  CAS  PubMed  Google Scholar 

  • Zorai A, Hartevelt CL, Bakir A, Van Delft P, Falfoul A, Dellagi K, Abbes S, Giordano PC (2002) Molecular spectrum of alpha-thalassemia in Tunisia: epidemiology and detection at birth. Hemoglobin 26:353–362

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The experiments comply with the current laws in the country in which they were performed.

Conflict of interest statement

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Le Gallais.

Additional information

Communicated by Susan Ward.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Touhami, I., Fattoum, S., Bibi, A. et al. The epidemiology of abnormal hemoglobins in Mediterranean high-level athletes. Eur J Appl Physiol 108, 1075–1081 (2010). https://doi.org/10.1007/s00421-009-1314-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00421-009-1314-0

Keywords

Navigation